| Literature DB >> 31288594 |
Timothy G Bowler1, Kith Pradhan1, Yu Kong1, Matthias Bartenstein1, Kerry A Morrone1, Ashwin Sridharan1, Rachel M Kessel1, Aditi Shastri1, Orsi Giricz1, Tushar D Bhagat1, Shanisha Gordon-Mitchell1, Mersedeh Rohanizadegan1, Lauren Hooda1, Ishan Datt1, Bartlomiej P Przychodzen2, Simrit Parmar3, Shahina Maqbool1, Jaroslaw P Maciejewski2, Ulrich Steidl1, John M Greally1, Amit Verma1.
Abstract
The MLL3 gene has been shown to be recurrently mutated in many malignancies including in families with acute myeloid leukemia. We demonstrate that many MLL3 variant calls made by exome sequencing are false positives due to misalignment to homologous regions, including a region on chr21, and can only be validated by long-range PCR. Numerous other recurrently mutated genes reported in COSMIC and TCGA databases have pseudogenes and cannot also be validated by conventional short read-based sequencing approaches. Genome-wide identification of pseudogene regions demonstrates that frequency of these homologous regions is increased with sequencing read lengths below 200 bps. To enable identification of poor quality sequencing variants in prospective studies, we generated novel genome-wide maps of regions with poor mappability that can be used in variant calling algorithms. Taken together, our findings reveal that pseudogene regions are a source of false-positive mutations in cancers.Entities:
Keywords: AML; MLL3; pseudogenes
Year: 2019 PMID: 31288594 DOI: 10.1080/10428194.2019.1630620
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022